Morgan Stanley Picks 3 Stocks to Watch in 2024: Delta, Keysight, and Natera

As we approach the end of 2023, the experts at Morgan Stanley have some insights for investors looking to the future. Despite some uncertainties right now, they believe there's a chance for companies to bounce back in 2024. Let's take a look at their top three stock picks for the coming year.

1. Delta Airlines (DAL): Flying High in a Challenging Sky

Delta Airlines, a big player in the world of air travel, is catching the eyes of experts. They have a strong reputation, and people like to fly with them. Even though the airline industry faces challenges like the cost of fuel going up, Delta is finding ways to make things work.

An expert at Morgan Stanley thinks Delta could make a lot of money in the coming years. They expect Delta to earn more than $7 per share in 2024 and maybe even $10 per share by 2027. That's a big deal!

Despite tough times, Delta recently shared some good news in its latest report. They made more money than people expected them to. This is especially impressive because many thought they would struggle. The expert at Morgan Stanley thinks Delta's stock could go up a lot from where it is now.

2. Keysight Technologies (KEYS): Behind-the-Scenes Tech Support

Next up is Keysight Technologies. They're like the tech support for other tech companies. Keysight makes tools and instruments that help make sure our electronic devices work correctly. From phones to cars, they've got it covered.

Even though their stock price has gone down a bit this year, there's hope. In their most recent report, they did better than people thought they would. They made more money than expected, and that's always good news. The expert at Morgan Stanley thinks the future looks bright for Keysight, and their stock could go up by a good amount.

3. Natera (NTRA): Small Tests, Big Impact

Last but not least, we have Natera, a company doing some cool things in the world of healthcare. They're like the detectives of DNA, helping doctors understand what's going on in our bodies. Natera's tests are like health detectives that can figure out if we have certain diseases or conditions.

Natera has been doing well lately. In their last report, they made more money than people thought they would. The expert at Morgan Stanley really likes what Natera is doing, especially with their cancer tests and helping with organ transplants. They believe Natera's stock could go up by a good amount in the next year.

So, there you have it – Morgan Stanley's top picks for 2024. These companies are doing interesting things, and experts think they could be a good investment. Remember, investing always involves some risks, but these picks are worth keeping an eye on!

Also Read: Charlie Munger, Longtime Partner of Warren Buffett and Investing Legend, Passes Away at 99